Orthostatic hypotension in familial amyloid polyneuropathy
- 1 October 1981
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 31 (10) , 1323
- https://doi.org/10.1212/wnl.31.10.1323
Abstract
We measured plasma norepinephrine levels in patients with familial amyloid polyneuropathy. Patients with orthostatic hypotension had low basal plasma norepinephrine levels, which did not increase after postural change. On the basis of biochemical findings that suggest depletion of peripheral norepinephrine, DL-threo-3,4-di-hydroxyphenylserine, an immediate precursor of norepinephrine, was given orally. Six hundred mg of this drug induced substantial and sustained elevation of blood pressure for several hours, and plasma norepinephrine content, increased. Daily administration for 4 weeks improved postural dizziness and syncope, and daily activity increased.This publication has 7 references indexed in Scilit:
- Effect of infused L-threo-3,4-dihydroxyphenylserine on adrenergic activity in patients with familial amyloid polyneuropathyEuropean Journal of Clinical Pharmacology, 1980
- Catecholamine metabolism in familial amyloid polyneuropathyClinical Genetics, 1979
- Plasma Levels of NorepinephrineAnnals of Internal Medicine, 1978
- Characteristics of enzymic decarboxylation of L-threo-3,4-dihydroxyphenylserine using hog renal L-aromatic amino acid decarboxylaseBiochemical Pharmacology, 1978
- Use of plasma norepinephrine for evaluation of sympathetic neuronal function in manLife Sciences, 1976
- TREATMENT OF NEUROGENIC ORTHOSTATIC HYPOTENSION WITH A MONOAMINE-OXIDASE INHIBITOR AND TYRAMINE1976
- INHIBITORY EFFECT OF (+)THREO-3,4-DIHYDROXY-PHENYLSERINE (DOPS) ON DECARBOXYLATION OF (−)THREO-DOPSThe Japanese Journal of Pharmacology, 1976